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Molecular Analysis of a Deletion Hotspot
in the NRXN1 Region Reveals the Involvement
of Short Inverted Repeats in Deletion CNVs
Xiaoli Chen,1,2,3,11 Yiping Shen,2,3,4,5,11 Feng Zhang,6 Colby Chiang,2 Vamsee Pillalamarri,2
Ian Blumenthal,2 Michael Talkowski,2,7,8 Bai-Lin Wu,3,5,9,* and James F. Gusella2,8,10,*
NRXN1 microdeletions occur at a relatively high frequency and confer increased risk for neurodevelopmental and neurobehavioral
abnormalities. The mechanism that makes NRXN1 a deletion hotspot is unknown. Here, we identified deletions of the NRXN1 region
in affected cohorts, confirming a strong association with the autism spectrum and other neurodevelopmental disorders. Interestingly,
deletions in both affected and control individuals were clustered in the 50 portion of NRXN1 and its immediate upstream region. To
explore the mechanism of deletion, we mapped and analyzed the breakpoints of 32 deletions. At the deletion breakpoints, frequent
microhomology (68.8%, 2–19 bp) suggested predominant mechanisms of DNA replication error and/or microhomology-mediated
end-joining. Long terminal repeat (LTR) elements, unique non-B-DNA structures, andMEME-defined sequencemotifs were significantly
enriched, but Alu and LINE sequences were not. Importantly, small-size inverted repeats (minus self chains, minus sequence motifs, and
partial complementary sequences) were significantly overrepresented in the vicinity of NRXN1 region deletion breakpoints, suggesting
that, although they are not interrupted by the deletion process, such inverted repeats can predispose a region to genomic instability by
mediating single-strand DNA looping via the annealing of partially reverse complementary strands and the promoting of DNA replica-
tion fork stalling and DNA replication error. Our observations highlight the potential importance of inverted repeats of variable sizes in
generating a rearrangement hotspot in which individual breakpoints are not recurrent. Mechanisms that involve short inverted repeats
in initiating deletion may also apply to other deletion hotspots in the human genome.Introduction
Neurexins are cell-surface proteins that bind to neuroligins
to form a trans-synaptic complex.1,2 The human neurexin
1 gene (NRXN1 [MIM 600565]) maps to chromosome
2p16.3 and spans a large genomic segment of 1.1Mb
(hg18, chr2: 49999147–chr2: 51113177).3 NRXN1 has
two independent promoters that generate two major iso-
forms: alpha-neurexins encoded by the longer transcript
and beta-neurexins encoded by the shorter transcript.4
This gene was initially implicated in autism spectrum
disorders (ASDs [MIM 209850]) by cases of heterozygous
inactivation resulting from a balanced translocation and
from de novo deletion and, subsequently, by numerous
copy-number variants (CNVs) and individual mutations.
This suggests that the disruption of NRXN1 is among
the strongest ASD susceptibility candidates identified to
date.5–14 NRXN1 deletions have also been linked to schizo-
phrenia (MIM 181500),15–27 intellectual disability and
language delay, epilepsy (MIM 614325), and attention
deficit hyperactivity disorder (MIM 143465),7,28–35 sug-
gesting that these deletions confer genetic risk across
a broad range of neurodevelopmental and/or neuropsychi-
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The Amecases of incomplete penetrance and compound heterozy-
gosity of NRXN1 deficiency have also been reported.28,35
Unlike recurrent deletions mediated by flanking terminal
repeats, NRXN1 deletions vary in size and location.14,35
The observation of frequent rearrangement of NRXN1
suggests that it is peculiarly susceptible to mutational
mechanisms that drive dosage imbalance and predispose
individuals to risk of neuropsychiatric disorders. In this
study, we examined two independent affected cohorts for
the association of NRXN1 deletions with abnormal neuro-
development and used deletion breakpoint mapping and
sequence analysis to examine the characteristics of the
mechanisms that underlie the nonrecurrent CNV forma-
tion in this gene.Subjects and Methods
Ascertainment of NRXN1 Region Deletions
Raw chromosomal microarray data generated from clinical genetic
testing at Children’s Hospital Boston (CHB cohort) with the
Agilent 244K comparative genomic hybridization (CGH) array
were reanalyzed with the use of Nexus software (BioDiscovery, EI
Segundo, CA, USA). A total of 6,623 probands with a broad range
of neurodevelopmental disorders were included in the study. Weenetic Research, Massachusetts General Hospital, Boston, MA 02114, USA;
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Table 1. Exon-Crossing Deletions in NRXN1 and Other Large
Autosomal Genes in the Neurodevelopmental Disorder Cohort and
Control Individuals
Locus
Affected
Individual Control
Enrichment in
Affected Individuals
NRXN1 12 1 1.10 3 105
WWOX 15 6 2.55 3 104
SPAG16 7 2 6.58 3 103
CTNNA3 53 72 9.95 3 103
PTPRT 6 3 3.54 3 102
NRG3 4 2 8.86 3 102
GPC6 3 1 1.01 3 101
GALNTL6 2 0 1.03 3 101
MAGI2 2 0 1.03 3 101
MACROD2 11 16 2.23 3 101
DLG2 4 4 2.34 3 101
CSMD3 2 1 2.43 3 101
KCNIP4 2 1 2.43 3 101
DAB1 1 0 3.21 3 101
FAM190A 2 2 3.86 3 101
CNTNAP2 3 4 4.02 3 101
FHIT 6 11 4.79 3 101
AUTS2 2 3 5.15 3 101
NRXN3 1 1 5.39 3 101
PTPRD 9 20 6.19 3 101
RBFOX1 10 23 6.52 3 101
PARK2 15 35 6.77 3 101
DPP6 1 2 6.87 3 101
PTPRN2 1 2 6.87 3 101
GRID2 1 3 7.88 3 101
CDH13 1 3 7.88 3 101
ANKS1B 2 7 8.39 3 101
GPC5 1 5 9.02 3 101
CSMD1 1 6 9.34 3 101
LRP1B 2 17 9.94 3 101
AGBL4 0 1 1.00 3 100
OPCML 0 0 1.00 3 100
ERBB4 0 5 1.00 3 100
CTNNA2 0 2 1.00 3 100
SGCZ 0 1 1.00 3 100
EYS 0 26 1.00 3 100
CNTN5 0 9 1.00 3 100
NRG1 0 1 1.00 3 100
CDH12 0 1 1.00 3 100
SOX5 0 4 1.00 3 100
Table 1. Continued
Locus
Affected
Individual Control
Enrichment in
Affected Individuals
DPP10 0 3 1.00 3 100
PRKG1 0 6 1.00 3 100
ACCN1 0 0 1.00 3 100
PARD3B 0 4 1.00 3 100
NKAIN2 0 2 1.00 3 100
In the neurodevelopmental disorder cohort, N ¼ 6,623. In control individuals,
N¼ 13,991. Significance, p < 1.13 103 based on the analysis of 45 indepen-
dent genes.
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ASD families (1,441 individual subjects) from the Autism Genetic
Resource Exchange (AGRE, the ASD research cohort). Deletion was
called by Birdsuite software.36 The longest NRXN1 transcript
(chr2: 49999147–chr2: 51113177) and the area 200 kb upstream
of this transcript were arbitrarily defined as the NRXN1 genomic
region (chr2: 49999147–chr2: 51317000), and deletions with at
least one breakpoint in this region were counted as NRXN1 region
deletions.
In order to analyze the association between NRXN1 region
deletion and broad neurodevelopmental disorders, we used two
control populations. First, we evaluated NRXN1 region dele-
tion in 13,991 apparently healthy individuals from whom we
had genome-wide CNV information, as previously reported
(Table 1).37 This control group was also utilized for the assessment
of structural variation within other genomic loci. The second
control group consisted of 49,996 control individuals from litera-
ture reports that specifically investigated NRXN1 deletion as a risk
factor in ASD or schizophrenia.9,11,15–17,20–22,25–27 In order to
minimize the cross-platform bias in CNV detection in the litera-
ture-derived data, we reviewed only deletions larger than 100 kb
for frequency comparisons in these affected individuals. These
literature reports were also used to compare NRXN1 deletions in
schizophrenia subjects. The study was approved by the institu-
tional review boards at Partners HealthCare and Children’s
Hospital Boston.
Deletion Breakpoint Mapping by Long-Range PCR
Multiple PCR primer pairs were designed around the approximate
breakpoints determined by microarray profiles. Long-range PCR
was used for the amplification of the junction sequence fragment.
In addition, we retrieved the junction sequences of six NRXN1
deletions from the literature and from the 1000 Genomes Project
(Table S1).30,38
Junction Sequence Analysis
For each mapped breakpoint, we downloaded 300 bp of junction
sequences flanking the breakpoint for the following analyses: (1)
many-to-many pairwise alignments (to search for long palin-
dromes between the proximal and distal junction sequence); (2)
Z-Hunt and non-B DB search (to identify non-B-DNA structures,
including direct repeats, inverted repeats, mirror repeats, A-phased
repeats, etc.); (3) RepeatMasker 3.2.7 (to search for repetitive
elements, including short interspersed nuclear elements [SINE],
long interspersed nuclear elements [LINE], long terminal repeat
[LTR] and DNA repeat elements, low-complexity repeats, and, 2013
RNA repeats); and (4) MEME Suite (to identify sequence motifs).39
All of these bioinformatic tools were run with the default settings,
and both the plus and minus DNA strands were analyzed. Motifs
identified in both the plus and reverse strands were named ‘‘minus
sequence motifs.’’ In order to locate the minus sequence motifs
near breakpoints, 300 bp of reference sequence surrounding the
site of each breakpoint (i.e., 150 bp from the nondeleted side
and 150 bp from the deleted side) were joined to the equivalent
300 bp from the site of the corresponding breakpoint at the other
edge of the deletion to form a 600 bp sequence formotif searching.
Motifs crossing the artificial junction created were discounted. In
order to confirm the association of detected sequence motifs and
repetitive elements with NRXN1 deletion events, we created a set
of 100 simulated deletions (and, therefore, 200 individual break-
points) by choosing a random location in NRXN1 and then
choosing a random deletion length (>600 bp) centered about
that location. The deletion length was random about a normal
curve with the average empirical deletion size (141,651 kb) and
SD (133,845 kb). The flanking sequences of the simulated dele-
tions (see Table S7) were analyzed as described above for minus
sequence motifs.Statistical Analysis
A c2 test or Fisher’s exact test was used for categorical variables.
Logistical regression was used for analyzing the association
between NRXN1 deletion and ASD and neurodevelopmental
disorders.Results
NRXN1 Exon Deletion Is Enriched in Individuals with
Neurodevelopmental Disorders and ASD
To compare the deletion of NRXN1 and its immediate
upstream region with other large genes, we tallied all intra-
genic CNVs for the 45 largest autosomal human genes with
reliable array CGH data in a CHB cohort of 6,623 probands
with broad neurodevelopmental disorders for comparison
with 13,991 control individuals (Table S2). Genes on
the X chromosome, such as DMD (MIM 310200), were
excluded from this analysis because of the technical chal-
lenge caused by sex mismatch in genomic hybridization.
Of the 23NRXN1 region deletions identified in this clinical
cohort, 12 crossed exons and, therefore, definitely affected
expression of the protein (Table S3 shows the location
and length of the NRXN1 deletions). Indeed, NRXN1
showed the greatest enrichment in affected individuals
for exon-crossing deletions among the 45 large autosomal
genes (12/6623 versus 1/13991, p¼ 1.103 105, one-sided
c2 test with Yates correction) (Table 1). However, the
NRXN1 region deletions that did not cross exons were
not significantly enriched in affected individuals over
control individuals (11/6623 versus 19/13991, p ¼ 0.70,
Fisher’s exact test), suggesting that most of such deletions
may not confer increased neurodevelopmental risk. To
address this question more extensively in the literature-
derived data set, we compared only NRXN1 region dele-
tions larger than 100 kb in order to minimize any cross-
platform bias in CNV detection (Table S4). We found thatThe Amesuch large deletions provided a more significant enrich-
ment (16/6623 versus 18/49996, p ¼ 1.393 1010, Fisher’s
exact test) than exon-crossing deletions alone (11/6623
versus 10/49996, p ¼ 6.55 3 109, Fisher’s exact test), sug-
gesting that at least some large deletions confer neurodeve-
lopmental risk without directly disrupting NRXN1 exon
sequences. Logistic regression showed that NRXN1 exonic
deletions larger than 100 kb resulted in an 8.32-fold
increase in risk (95% confidence interval, 3.53–19.59)
for neurodevelopmental disorders. Notably, some of the
other large genes with frequent intragenic deletions
(Table S2) have been implicated previously as ASD-related
genes,11,40,41 although comparison of the frequency of
exonic deletions in the CHB cohort and 13,991 control
individuals suggests only WWOX (MIM 605131) (p ¼
2.55 3 104) as a significant ASD candidate gene (Table 1).
In the ASD research cohort from AGRE, we identified
13 individuals with NRXN1 region deletion, 11 with non-
exonic deletions, and 2 with exonic deletions (Table S3).
As expected, exon-crossing NRXN1 deletions were sig-
nificantly enriched in the ASD research cohort (2/751
versus1/13991, p ¼ 0.0004, c2 test with Yates correction),
as previous findings reported.9,11 Data from the two inde-
pendent affected cohorts support the view that exonic dele-
tions ofNRXN1 are associated with increased risk of neuro-
developmental disorders and ASD.9,11,15–17,20–22,24,26,27
Parental testingwas available for 24NRXN1 region deletion
carriers across both clinical diagnostic and ASD research
cohorts, revealing that five deletions (four of which were
exon-crossing) were de novo (Table S3).
Deletions Are Clustered in the 50 Half of the NRXN1
Region
From the two affected cohorts, 36 NRXN1 region dele-
tions (all but four with both breakpoints within chr2:
49999147–chr2: 51317000), displayed as a custom track
in the University of California, Santa Cruz (UCSC)
Genome Browser (Figure 1), showed an uneven distribu-
tion; the majority of the breakpoints being located in the
50 portion of this 1.3 Mb region. After subdividing the
region into two halves at the genomic midpoint in intron
5, we observed 59 breakpoints in the 50 half (chr2:
50658073–chr2: 51317000, 658 kb) and nine breakpoints
in the 30 half (chr2: 49999147–chr2: 50658073, 658 kb),
indicating a significant enrichment in the former (59/
658 versus 9/658, p ¼ 4.77 3 1010, Fisher’s exact test).
This enrichment applied to the subset of breakpoints
from five de novo deletions (9/658 kb versus 1/658 kb,
p¼ 0.02, c2 test with Yates correction). The same clustering
is also observed forNRXN1 deletions in normal individuals
reported in the Database of Genomic Variants (DGV) (29/
658 kb versus 3/658 kb, p ¼ 3.27 3 106, Fisher’s exact
test) and for NRXN1 deletions detected in individuals
with schizophrenia (125/658 kb versus 3/658 kb, p ¼
4.77 3 1010, Fisher’s exact test).27 This consistent break-
point-clustering phenomenon across different diagnostic
categories and controls suggests that there is an underlyingrican Journal of Human Genetics 92, 375–386, March 7, 2013 377
Figure 1. NRXN1 Deletions Identified from Individuals with Neurodevelopmental Disorders, Schizophrenia Cohorts, and the Data-
base of Genomic Variants Controls Displayed as UCSC Genome Browser Custom Tracks
The RefSeq Genes track shows the 1.3 Mb NRXN1 region encompassing the longest transcript and 200 kb upstream (chr2: 49990147–
chr2: 51317000), and the black arrow indicates the genomic midpoint of this region. Red bars indicate 37 deletions identified from indi-
viduals with neurodevelopmental disorders (36 from this affected cohort and one from a literature-reported ASD individual). From our
affected cohort, 26 NRXN1 deletions were mapped at the nucleotide level. Grey bars indicate five deletions identified from control indi-
viduals with exact breakpoint mapping. The purple and green lines indicate NRXN1 region plus and minus self chains, respectively. The
relative positions of 66 NRXN1 region deletions reported in the literature for individuals with schizophrenia are shown as maroon bars.
Deletions in control individuals reported in the DGV are shown in the bottom panel. Three independent deletion breakpoints (blue
arrow, affected individuals 1 and 34 and 1KG-4) were close to the sameminus self chain. The yellow arrow indicates an identical deletion
in affected individuals 19 and 20. The green arrows indicate minus self chains in close association with NRXN1 breakpoints.
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genomic basis for the 50 half of this NRXN1 region being
a relative hotspot for deletion; the consequence being
that particularly large or exon-crossing deletions confer
neurodevelopmental risk.
To explore this question, we compared the general
genomic features between the 50 and 30 halves of the
region. Segmental duplications, also known as low-copy
repeats (LCRs), were not identified in NRXN1, consistent
with the observation that most NRXN1 deletions are
nonrecurrent and provide no support for nonallelic
homologous recombination (NAHR) in their generation.
Notably, significantly more self chains, a kind of short
low-copy repeat in the human genome (self chain data
have been archived in UCSC Genome Browser,42 were
found in the 50 half than in the 30 half of the NRXN1
region (174 versus 28, p ¼ 6.04 3 1029, c2 test). The
50 half also had more intrachromosomal self chains
with homology on chromosome 2 than the 30 half (27
versus 10, p ¼ 0.004, c2 test). To examine the potential
roles for these self chains in generating deletions, we
filtered out those with homology outside the NRXN1
region and investigated only those in which both chain
pairs were located. This left ten and nine self chains in
the 50 half and the 30 half of NRXN1, respectively (Table
S5 for detailed location of NRXN1 region self chains).
Intriguingly, when separating self chains into plus (þ)
and minus () groups (plus indicates direct repeats,
minus indicates inverted repeats), we noted that minus
self chains coincided with deletion clustering in the 50
half of the NRXN1 region (Figure 1). Six minus self chains
appeared to cluster in the 50 half region, and only one
appeared to cluster in the 30 half (Fisher’s exact test,
p ¼ 0.12), whereas the plus self chains did not exhibit
such a differential distribution. As exemplified in
Figure S1, minus self chains are, in essence, inverted
repeats, each representing a segment of a few hundred
base pairs, separated from each other by several hundred
to a few thousand base pairs. Such sequences can poten-
tially form cruciform structures and induce genomic
instability. Minus self chains are present in the vicinity
of 12 NRXN1 region deletions (at distances < 20 kb; see
Table S6), and the lengths of base-matched sequences
were 329–944 bp (Table S5). Intriguingly, one minus
self chain is located near the breakpoints of two indepen-
dent deletions (affected individuals 34 and 1 near the
same minus self chain chr2: 51077779–chr2: 51078561;
see blue arrow in Figure 1). The coinciding distributions
of minus self chains with deletion breakpoints and their
clustering at the 50 end of the NRXN1 region suggest
the potential involvement of inverted repeats in the
process of deletion at this gene. In addition, we identified
significantly more LTR sequences (116/658 kb versus
56/658 kb, p ¼ 9.26 3 107, c2 test), interrupted repeats
(79/658 kb versus 37/658 kb, p ¼ 4.43 3 105, c2 test),
and G-quadruplex-forming repeats (36/658 kb versus
18/658 kb, p ¼ 0.01, c2 test) in the 50 half in comparison
to the 30 half of the NRXN1 region. These non-B-DNAThe Amesecondary structures may provide a landmark function
for targeting specific genomic instability and
rearrangements.
Junction Sequence Characteristics: Microhomology
and Palindromic Elements
To further investigate sequence characteristics at deletion
junctions, we mapped out the 52 deletion breakpoints
from 26 affected individuals at the nucleotide level using
long-range PCR and sequencing. Table 2 lists junction
sequence characteristics of these 26 deletions and 6 dele-
tions retrieved from the literature and the 1000 Genomes
Project (27 deletions in affected individuals and 5 in
control individuals; see Figure 1), ranging from 116 bp
to 635 kb in size.We detected a high frequency ofmicroho-
mology at the deletion junctions (22/32 [68.8%], 2–19 bp),
which was consistent with either replication-based mecha-
nisms, such as microhomology-mediated break-induced
replication (MMBIR), fork stalling and template switch
(FoSTeS), serial replication slippage (SRS), or a double-
strand DNA break (DSB) repair mechanism such as micro-
homology-mediated or alternative end joining (MMEJ or
alt-EJ). Five affected individuals (affected individuals 4,
27, 40, 45, and 1KG) showed small inserted segments iden-
tical to the sequences at or near the distal breakpoints.
Affected individual 40 showed a complex rearrangement
pattern and the presence of an A nucleotide at all four
breakpoints, suggesting an unstable replication process
appearing as SRS (Figure S2). Furthermore, 37.5% (12/32)
of deletions had one breakpoint in a LINE or Alu repeat
(Table S6). Although very short insertions were observed,
no microhomology was found at the junctions in affected
individuals 31 (7 bp), 36 (9 bp), and 2 (1 bp), indicating the
involvement of a nonhomologous end-joining (NHEJ)
repair mechanism. Two small-size benign deletions (in
individuals 1KG-3 and 1KG-4), whose sizes are almost
the same as the LINE and Alu elements removed, may
reflect retrotransposition. In addition, the breakpoints
of three deletions (in1KG-4 and affected individuals 1
and 34) are closely associated with the same minus self
chains chr2: 51077779–chr2: 51078561 (see blue arrow
in Figure 1).
Furthermore, we performed sequence motif searches at
junction sequences, particularly for pairs of motifs with
reverse complementary sequences (named here ‘‘minus
sequence motifs’’; Figure S3). We discovered ten deletions
carrying minus sequence motifs (the distance to the break-
point <150 bp). In three subjects (affected individuals 19,
20, and 41), two different minus sequence motifs were
found adjacent to both proximal and distal breakpoints
(Figure S3). To test whether this finding was statistically
significant, we randomly generated 100 simulated dele-
tions comprising 200 simulated breakpoints and searched
for minus sequence motifs. We found that the sequences
participating in actual deletion events displayed signifi-
cantly more minus sequence motifs near the breakpoints
than the simulated deletions (12/32 versus 8/100, Fisher’srican Journal of Human Genetics 92, 375–386, March 7, 2013 379
Table 2. Characteristics of Junction Sequences for 32 NRXN1 Region Deletions
Individual
ID
Size of
Deletion Sequence Profilea
Microhomology
(Bases)
Origin of Inserted
Sequence
1 64 kb TCTGTCCAATCTGCCATgaaataaattc..aggaaaattgtgcatAATAAGCACATAA 3 none
2 17 kb CAAAGTCTCACAGActtcccccat..C..gatgtttgctttctaTCACCTGACTCTAGGA 1 unknown
4 20 kb AGTAATTTTGTGTGTCCTAATGCAAATTTcctttttt..AGATACTGATAATCTAAAATTA..att
aaatttGATACTGATAATCTAATTCC
6 near downstream
breakpoint
5 21 kb ACCTGAAGTTTTCTTTTTTTTTGTtgtatctct....aagaatatCATCACTCCATTTGTTCTGCTCC 1 none
6 25 kb ACTGATGGGCAtttgggttgg..cactactcccaCCTCTAAGTCAA 2 none
10 44 kb ACCTTGGGCAAGCATTTaatctctccaaatct..ttggataaagaggaattCCTCAAGTCCTACGTT 2 none
11 49 kb TACAATGGCTAGCCCTGGATccatttggtaacaatct..ttagtcccatttgattatATCATTTCCTGACA 2 none
12 64 kb AGGCCTGTGAAGGCCTTgctctatattctacct..gaaaataaggtattaccttTGCTGAATTTAGTTT 4 none
14 66 kb ATATTAAACTCAAAGTTGctgtgaccttattgtatt..atagttgaaaatgccttaggttgTGCAGTGGTAGA
TGTTTTTTAA
4 none
18 70 kb AACTATGCTCAAAATGTGTAatattgaaaataatactta..ctaagtacaccacaTACTCAAAAGGT
AAGCTCC
1 none
19 and 20 73 kb GGCTAGCAGCAGAACAGcttcttccctggtaaaaccagag..cattaaagaacaagAGAGCATGGAG
TTGACTAT
2 none
21 76 kb CTTTCAAACCAGACACTATtcctaaccaaaaatatg..ctagagagaaaaaatAAATCAAACACAATTCAT 2 none
27 103 kb CCTGCACACACTCTCTTGCCTGctgcc..tgTGTGTCT..agtgtgTGTCTCTGTGTGTTAAA
TCATCC
2 at downstream
breakpoint
29 123 kb CTAATGAGTGGAGTCCAGGATTCagacatagccgatccaaccc..gcagtctggccaccatcTGGCAA
GGCAACTGTGC
2 none
31 146 kb ACATTGTAGCTAATGCAGGAAGacaagaaaagt..CTACATG...ccttggtCACTGGTTGAA
TTTTTTATATCTC
none unknown
32 147 kb GAGAAGACGGGTGACACCTGAgagtgtttggg..agagggttacatgctgaTAAAATGATGTACTG
AATTA
4 none
34 150 kb AATCAATGACTATTCCTGTGGCATAAaccag...tagctgtGTTAATTTGAGTGAGTTAAT none none
35 158 kb CTGAAGCCAGCAGAGAGCAtcattaaaaattccca..gtctgagttgctctcggagcaACCAAACTAAAATAT 5 none
36 176 kb AATGACATGAAGGATTCTGACATTtagaaaactag..ACAGAATTA..taagttcTAACCAGTAT
AAGTCCAC
none unknown
39 247 kb ACTAAAGCCACCACAGATCTGCcttgaatcggtattctcaa..aaaagcagtctttagctgcTTGGCTGGT
AAAATTA
4 none
40 249 kb GGCACACCTTTATATAgttcactaattttttt..aATTTGAAAAAAATTTGAAAAAAATTTGA..ttgttt
gtggaATTTGAAAAAAAGAAGCCATT
1 at downstream
breakpoint (3X)
41 264 kb CCTTCTTAGCTAAATGCCcctgtgcaaggc..attgcaactacccAGATCAAAGGTTATTCATTA 2 none
42 286 kb GAGGTTAGGTGTCTCTGCTTtcaagtaaggtaaacttgagtt..aatcaagccattcttgattCCTCT
CAGGAGAAAGAATGTTTTCT
2 none
43 331 kb AACAAGCCTAGTAAGTAGCATTattaggagaaatttct.. tgcttataatgtctttCTATATAAGATACGTA 2 none
45 635 kb AAGAACAAAAACAAgttttctcgggaact..aaTCTACATCTTTATTTCT..cttcttgtatgttatAATCTA
CATCTTTATTT
2 near downstream
breakpoint
Family 1 378 kb ATATGTAATTAATTGTGTCtcacaggatgttaa..tctttaataattcCCAGCAAGTAATTGGACAT 2 none
v39249 11 kb ATTAATATACCATAAATAATAAGAGTGTGTGTGTGTGTGTGTGagcgc..ccctttga
gtgtgtgtgtgtgtgtgtgTGTGTGAAAAATAGATACACAA
19 none
1KG-1 763 bp TTTTTTTGTTGTATCTCTGgtagg.tgcttAGTAGAAACAGTAACAGCAAAA none none
1KG-2 116 bp GTACCATGTCATTGACTTTAAACACACAGTAGGAtggag..GGA..taggaGACATTTCTA
AAAGCTATT
5 at downstream
breakpoint
1KG-3 321 bp ACAGAACATATAATTCTTTCAATATTCtgaa..ggccGAACTTTTGTTTCTTATTTAAA 1 none
1KG-4 996 bp ACAAAAAAAGATACTCTGCATAGAAATTaatca..tctttcACATTCAAACTGCCTTTTACATT
AATGGA
none none
aSmall letters are deleted sequences, capital letters on each side are remaining sequences, capital letters in the middle are inserted sequences, underlined
nucleotides indicate microhomology, and bold italic nucleotides are complementary.
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exact test, p ¼ 0.0002). None of the motifs from the simu-
lated breakpoints matched the sequence of those from the
actual breakpoints. Seven affected individuals (affected
individuals 6, 11, 19, 20, 27, 29, and 41) had minus
sequence motifs located on opposite sides of the deletion,
which was also significantly more than in the random
deletions (7/32 versus 5/100, Fisher’s exact test, p ¼
0.008). This enrichment of minus sequence motifs in
the immediate vicinity of deletion breakpoints suggests
the potential involvement of such sequence motifs in the
formation of these deletions.
We identified two identical deletions (affected individ-
uals 19 and 20) that were maternally inherited in unrelated
families (see yellow arrow in Figure 1). It is not known
whether these reflect recurrent events or segregation of
this deletion in the population. Upon detailed examina-
tion of the junction characteristics, we noted both micro-
homology and three different sizes of inverted repeats at
this recurrent deletion (Figure S4). The bilateral breakpoint
showed 2 bp microhomology and 12 bp short partially
complementary sequences. A pair of inverted sequence
motifs was also present within the deleted region. In addi-
tion, a minus self chain with a 240 bp matched inverted
repeat was located within 5 kb. The combination of these
features suggests a model in which the partially reversed
complementary sequences create a structural substrate
for recurrent deletions via single-strand DNA looping at
the exact same location within a region in which genomic
instability is promoted by a nearby minus self chain.
Similar short complementary sequences and microhomol-
ogy at the breakpoint were also observed in another
affected individual (affected individual 42) with a de
novo deletion (Table 2).Discussion
NRXN1 Is a Top Deletion Hotspot Conferring Risk to
a Wide Spectrum of Neurodevelopmental Disorders
The distribution of CNVs in the human genome is not
random.43 Some genomic regions are susceptible to CNV
mutations, known as CNV hotspots.44 Hotspots involving
recurrent deletions and duplications have been found to be
closely associated with large segmental duplications.44–46
Such recurrent CNVs are often large, involving multiple
genes, and presumably share identical breakpoint inter-
vals. Hotspots were also identified for nonrecurrent
CNVs.31 Unlike recurrent CNVs, many of the nonrecurrent
hotspots are intragenic; i.e., in the long intronic regions of
large genes.
In our study, we compared deletion within NRXN1 and
its immediate upstream region in both ASD and neurode-
velopmental disorder cohorts and control cohorts. These
two independent cohorts supported the proposition that
large (>100 kb) and exon-crossing intragenic deletions of
NRXN1 confer significantly increased risk to abnormal
neurodevelopment.9,11,15–17,20–22,24,26,27 Our data also sug-The Amegest that some large deletions that do not directly disrupt
NRXN1 exon sequences also confer neurodevelopmental
risk. The existence of many regulatory elements in large
intronic regions of NRXN1, as revealed by the ENCODE
Project, may explain the impact of some non-exon-
crossing deletions on gene function.47 NRXN1 is also
known to generate hundreds of alternatively spliced tran-
scripts, suggesting the possibility that intronic deletions
might also affect accurate splicing. A similar, though less
striking, enrichment was obtained for exon-crossing dele-
tions in WWOX, which encodes a protein with two
WW domains and a short-chain dehydrogenase/reductase
domain. WWOX deletions have been proposed to be
potentially pathogenic for autism and epilepsy.48 Our find-
ings further support the significant association of WWOX
exon-crossing intragenic deletion in autism and neurode-
velopmental disorders.
Previous studies have noted an uneven distribution
of deletions in NRXN1 and high amounts of clustering
in the 50 end region encoding alpha-neurexin 1 iso-
forms.27,31 Our data further illustrate such a focal deletion
hotspot at NRXN1, but this phenomenon is not specific to
individuals with neurodevelopmental disorders, given that
a similar pattern is observed in the normal population
(Figure 1), suggesting a basis in the genomic architecture
of the region. The striking difference in deletion density
between 50 and 30 halves of the same gene region offered
us a unique opportunity to identify genomic features
that could underlie this phenomenon.
NRXN1 Nonrecurrent Deletion via FoSTeS in a DNA
Replication Process
By analyzing precise nucleotide sequences around the
rearrangement sites, previous studies investigated the
mechanisms underlying CNVs.49,50 NAHR between LCR
pairs can cause recurrent rearrangements and lead to
genomic disorders, as in DiGeorge syndrome and Wil-
liams-Beuren syndrome, for example.51,52 However, our
data do not support NAHR as a mechanism for deletion
in the NRXN1 region, given that no LCR was identified
and most of the deletions are nonrecurrent. NHEJ is
another mechanism contributing to chromosomal abnor-
mality in cancer via the formation and repair of DSBs.50
Unlike in NAHR, no LCR is needed in NHEJ events to
form CNVs, but, instead, an information scar of additional
nucleotide(s) is usually left at the breakpoint junction
site.53 Evidence suggests that NHEJ is one of the key
mechanisms underlying nonrecurrent rearrangements.50
DNA replication fork stalling and template switching
(FoSTeS) is a recently identified mechanism for non-
recurrent and especially complex rearrangements due to
faulty DNA replication.54,55 A short, rather than a long,
stretch of microhomology is the key feature of the FoSTeS
process. By virtue of the short microhomology, the
lagging DNA replication fork transfers to the downstream
or upstream sequence rather than its own template, result-
ing in deletion or duplication CNVs. FoSTeS has beenrican Journal of Human Genetics 92, 375–386, March 7, 2013 381
observed in nonrecurrent and complex CNVs of PLP1,
PMP22, MECP2, and many other loci.54–56 We detected
a high frequency of microhomology (68.8%, 2–19 bp) at
NRXN1 deletions that is consistent with a recent genome-
wide sequencing study of CNV breakpoints that reveals
70%–79% microhomology, suggesting FoSTeS as a major
mechanism for the formation of deletion CNVs.57,58 In
particular, some individuals in our study show evidence
of repeated FoSTeS processes during a particular deletion
event, further supporting a replication-based mechanism.
Beyond these major mechanisms, SRS is another DNA
rearrangement mechanism involving DNA replication.59
SRS is the consequence of replication fork repair, in which
the fork switches back to the former template sequences
multiple times in order to repair the replication error.
Evidence for SRS is revealed in several NRXN1 dele-
tions, which are also consistent with a multiple FoSTeS
mechanism.
However, microhomology or FoSTeS mechanisms
cannot themselves explain the uneven occurrence of
deletions in NRXN1 or in any deletion hotspot in the
human genome. What are the other factors that induce
deletions at certain genomic regions? Lupski summarized
the general features in NAHR-mediated rearrangements
and pointed out that both homology and chromosomal
breakage are necessary features. In his opinion, chromo-
somal breakage might be the initiating event for recombi-
nation between LCR pairs.60 We hypothesize here that
features of the local genomic architecture, such as repeti-
tive elements (Alu and LINE), non-B-DNA (Z-DNA), and
sequence motifs that are susceptible to DNA replication
fork stalling and/or DSBs may also be involved in the initi-
ation of genomic deletions. Alu and LINE are non-LTR ret-
rotransposons that have been reported to have a profound
influence on genomic instability.61 Zhang et al. sequenced
the breakpoints of PMP22 deletions and found that
some breakpoints were located within the LINE or SINE
region.62 Non-B-DNA sequences include inverted repeats,
direct repeats, and mirror repeats.63 These specific DNA
sequences facilitate non-B-DNA conformation, which is
susceptible to DNA damage. Once damage happens, non-
B-DNA conformation makes the replication fork more
resistant to repair and causes damage accumulation.64
Sequence motifs are consensus sequences that have
distinctive secondary structure for binding or splicing
during DNA replication and transcription. They are also
reported to be associated with genomic instability.65
Recently, Vissers et al. analyzed the formation mechanism
for some rare pathogenic CNVs and observed that 75% of
tandem duplications were associated with one of two
sequence motifs.58 In our study, we identified sequence
motifs and repetitive elements (LTR sequences, inter-
rupted repeats, and G-quadruplex-forming repeats but
not Alu-SINE sequences) as enriched in the NRXN1 dele-
tion hotspot region, supporting a potential role for these
aspects of the local genomic architecture in NRXN1dele-
tion formation.382 The American Journal of Human Genetics 92, 375–386, March 7Short Inverted Repeats in the Formation of a Deletion
Hotspot
Using online analytic tool sets, we identified several
genomic features that showed differential distributions
between the 50 and 30 halves of the NRXN1 region. Among
them, minus self chains are often overlooked genomic
features. In essence, minus self chains are inverted repeats
of several hundred base pairs (300–1,000 bp) with ~90%
homology separated by sequences of several hundred or
thousand base pairs. The sequence characteristics of minus
self chains indicate that they are capable of mediating
single-strand DNA looping via the annealing of partially
reverse complementary sequences, which would thereby
promote DNA replication fork stalling. The close associa-
tion of minus self chains with several deletion breakpoints
and their biased distribution toward the 50 portion of
the NRXN1 region suggest that these sequences have a
potential role in destabilizing their vicinity and making it
prone to deletion. Besides minus self chains, two other
kinds of small inverted repeats, minus sequence motifs
(20–100 bp) and focal partial complementary repeats (4–
20 bp), were seen near NRXN1 breakpoint sites. These
small inverted repeats possess characteristics of those
palindromic sequences that may be associated with
genomic instability and underlie deletion or recombina-
tion hotspots in bacteria and eukaryotes.66–68 Inverted
repeats also contribute to many different pathogenic
genomic arrangements in humans, such as the palin-
dromic AT-rich repeat (PATRR) in recurrent intrachromoso-
mal ‘‘balanced’’ translocations.69–72 Recently, Carvalho
et al. uncovered the role of LCRs in complex duplication-
triplication mediated by very long inverted repeats
(>10 kb with 99% sequence similarity).73 Dittwald et al
described the genome-wide distribution of inverse paralo-
gous LCRs (IPLCRs) (>1 kb, 95% sequence identity) and
the potential risk of the IPLCRs in 1,455 human disease-
related genes.74 In addition, several locus-specific inverted
repeats were observed to mediate genomic rearrangement,
as in the cases of two interchromosomal insertions (125–
300 kb) in Xq27.175 and the recurrent intragenic CFTR
(MIM 602421) deletion (3.8 kb) triggered by a small in-
verted repeat (32 bp, 93%).76 Inverted repeats of different
sizes seem to initiate different rearrangement mechanisms.
PATRR is suspected to form cruciform structures that
lead to interchromosomal translocation by DSBs.77 IPLCRs
are believed to mediate rearrangement by an NAHR
mechanism.73 Small inverted repeats (<1 kb) mediate
interchromosomal insertion and deletion via a FoSTeS
mechanism.78 Our findings concerning the NRXN1 region
deletions suggest that, although microhomology provides
a primer for replication template reinitiation, it is not
sufficient for locating the reinitiation spot. Other geno-
mic structural features, such as various inverted repeats
mentioned above and non-B-DNA structures, may play
an important role in creating the initial substrate for repli-
cation-initiated genomic instability. Specifically, our data
suggest that, in the NRXN1 region, short inverted repeats, 2013
(several hundred bp in size) can destabilize their local
chromosomal vicinity by mediating DNA secondary struc-
tures that cause DNA replication fork stalling and induce
DNA replication errors, thereby predisposing this region
to deletions.
In summary, we characterized a deletion hotspot in the
50 half of the NRXN1 region that confers increased risk
for a broad range of neurodevelopmental disorders. After
mapping deletion breakpoints at the nucleotide level, we
revealed a high frequency of microhomology that suggests
predominant mechanisms of DNA replication error and/
or microhomology-mediated end-joining in forming dele-
tions. Importantly, however, the close physical association
and enrichment of short inverted repeats within the
NRXN1 deletion cluster leads to the hypothesis that short
inverted repeats may play an important mechanistic role
in predisposing this region to such replication-mediated
deletions.Supplemental Data
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